Form 4: Conmed Corp Executive Edward A. Clifford Reports Stock Option Grant

Edward A. Clifford, VP Global Manufacturing at Conmed Corp, reports the acquisition of 18,988 stock options on March 1, 2024.

Summary

• On March 5, 2024, Edward A. Clifford, VP Global Manufacturing at Conmed Corp, filed a Form 4.
• The form reports a transaction that occurred on March 1, 2024, where Clifford acquired 18,988 stock options with an exercise price of $79.95.
• These options were granted under the company's 2018 Long-Term Incentive Plan and vest in equal amounts over a five-year period.
• Following the reported transaction, Clifford directly owns 18,988 derivative securities.

Sentiment

Score: 6

Explanation: The document is a routine regulatory filing detailing a stock option grant. It's neutral in tone and doesn't indicate any significant positive or negative developments for the company.

Positives

• The grant of stock options to a key executive aligns their interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the executive.

Industry Context

Stock option grants are a common form of executive compensation in publicly traded companies, aligning management's interests with those of shareholders.

Stakeholder Impact

• The stock option grant aligns the executive's interests with those of the shareholders, potentially incentivizing them to increase shareholder value.

Key Dates